Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-LVLQTM-OH
3D-Ansicht

Biosynth logo

H-LVLQTM-OH

Ref. 3D-PP49091

1mg
189,00 €
10mg
195,00 €
100mg
349,00 €
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 27. Dezember 2024

Produktinformation

Name:
H-LVLQTM-OH
Beschreibung:

Peptide H-LVLQTM-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LVLQTM-OH include the following: Hand, Foot, and Mouth Disease Challenges and Its Antiviral Therapeutics Z Li, W Ji, S Chen, G Duan, Y Jin - Vaccines, 2023 - mdpi.comhttps://www.mdpi.com/2076-393X/11/3/571 Recent advances in enterovirus A71 infection and antiviral agents Y Wei, H Liu, D Hu, Q He, C Yao, H Li, K Hu - Laboratory , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0023683723002416 Structures and corresponding functions of five types of picornaviral 2A proteins X Yang, A Cheng, M Wang, R Jia, K Sun - Frontiers in , 2017 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fmicb.2017.01373/full Antiviral molecules of enteroviruses V Saarnio - 2017 - jyx.jyu.fihttps://jyx.jyu.fi/handle/123456789/52777 Efficient strategy to design protease inhibitors: Application to enterovirus 71 2A protease T Chen , C Grauffel, WZ Yang, YP Chen - ACS bio & med , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsbiomedchemau.2c00001 Advances in anti-EV71 drug development research S Wanga, Z Panga, H Fana, Y Tongab - researchgate.nethttps://www.researchgate.net/profile/Huahao-Fan/publication/369413384_Advances_in_anti-EV71_drug_development_research/links/6428d70b315dfb4ccec6e627/Advances-in-anti-EV-A71-drug-development-research.pdf Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice S Lalani , SH Tan , KO Tan , HX Lim , KC Ong , KT Wong - Life Sciences, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0024320521010845 Antiviral peptides against Enterovirus A71 causing hand, foot and mouth disease S Lalani , LT Gew , CL Poh - Peptides, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978120301923 Identifying novel antiviral targets against enterovirus 71: where are we? S Gunaseelan, JJH Chu - Future Virology, 2017 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.2217/fvl-2016-0144 Insight into the Enterovirus A71: A review R Kinobe , A Wiyatno, IM Artika - Reviews in medical , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/rmv.2361 EV-A71 Infections: Life Cycle and Prevention Strategies QL Tu, TT Nguyen , TT Tran, NHV Vo - VNU Journal of Science , 2023 - js.vnu.edu.vnhttps://js.vnu.edu.vn/NST/article/view/5288 Update on enterovirus 71 infection PN Huang , SR Shih - Current opinion in virology, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1879625714000674 Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A P Ren, Y Zheng, W Wang, L Hong, F Delpeyroux - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/srep42902 Ex Vivo and In Vivo Inhibition of Human Rhinovirus Replication by a New Pseudosubstrate of Viral 2A Protease N Falah, S Violot, D Decimo, F Berri - Journal of , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.05263-11 Blocking human enterovirus 71 replication by targeting viral 2A protease N Falah, R Montserret, V Lelogeais - Journal of , 2012 - academic.oup.comhttps://academic.oup.com/jac/article-abstract/67/12/2865/775113 Antivirals blocking entry of enteroviruses and therapeutic potential MI Anasir , F Zarif, CL Poh - Journal of biomedical science, 2021 - Springerhttps://link.springer.com/article/10.1186/S12929-021-00708-8 Sulfonated Azo Dyes Interact with Capsid of Human Enterovirus 71 to Modulate the Viral Infectivity, and Their Implication on the Viral Vaccine Design M Tao - 2019 - search.proquest.comhttps://search.proquest.com/openview/b195bfc7a1efd3b0e74d9187c7df31e2/1?pq-origsite=gscholar&cbl=2026366&diss=y Identification and characterization of new small molecule inhibitors of picornavirus replication LAF Siltz - 2016 - search.proquest.comhttps://search.proquest.com/openview/57c1b25bd6af0fb5a1a321939664ba6a/1?pq-origsite=gscholar&cbl=18750 Antiviral drug discovery for the treatment of enterovirus 71 infections L Shang, M Xu, Z Yin - Antiviral research, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166354212002859 Antivirals and vaccines for Enterovirus A71 L Jing-Yi, K Yu-An, SR Shih - Journal of Biomedical Science, 2019 - search.proquest.comhttps://search.proquest.com/openview/ff276e11ea33042622b4310da4b8f5a5/1?pq-origsite=gscholar&cbl=54111 Enzymes and enzyme activity encoded by nonenveloped viruses K Azad, M Banerjee, JE Johnson - Annual Review of Virology, 2017 - annualreviews.orghttps://www.annualreviews.org/doi/abs/10.1146/annurev-virology-101416-041944 Antivirals and vaccines for Enterovirus A71 JY Lin, YA Kung, SR Shih - Journal of biomedical science, 2019 - Springerhttps://link.springer.com/article/10.1186/s12929-019-0560-7 RNA-virus proteases counteracting host innate immunity J Lei , R Hilgenfeld - FEBS letters, 2017 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1002/1873-3468.12827 Development of antiviral agents toward enterovirus 71 infection HR Pourianfar , L Grollo - Journal of Microbiology, Immunology and , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1684118213002363 Enteroviruses and rhinoviruses G Wang - Molecular Medical Microbiology, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780128186190000629 Antimicrobial peptides and their potential application in antiviral coating agents ED Freitas , RA Bataglioli , J Oshodi - Colloids and Surfaces B , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0927776522003769 Recent developments in antiviral agents against enterovirus 71 infection CW Tan , JKF Lai, IC Sam , YF Chan - Journal of biomedical science, 2014 - Springerhttps://link.springer.com/article/10.1186/1423-0127-21-14 Strategies to identify and develop antiviral peptides CL Poh , S Lalani - Vitamins and Hormones, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0083672921000522 Development and characterization of a stable eGFP enterovirus 71 for antiviral screening B Shang, C Deng, H Ye, W Xu, Z Yuan, PY Shi - Antiviral research, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166354212002902

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP49091 H-LVLQTM-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.